CEA, CA125 and CA19-9 levels in congenital gastrointestinal anomalies

Baykal-Erkilic A., Erkilic M., MELİKOĞLU M., Aksu A.

TURKISH JOURNAL OF PEDIATRICS, vol.41, no.4, pp.473-481, 1999 (SCI-Expanded) identifier identifier identifier

  • Publication Type: Article / Article
  • Volume: 41 Issue: 4
  • Publication Date: 1999
  • Journal Indexes: Science Citation Index Expanded (SCI-EXPANDED), Scopus, TR DİZİN (ULAKBİM)
  • Page Numbers: pp.473-481
  • Keywords: tumor markers, anomalies, radioimmunoassay, TUMOR-MARKERS, MONOCLONAL-ANTIBODY, OVARIAN-CANCER, CA-125, ANTIGEN, DISEASE
  • Akdeniz University Affiliated: Yes


Preoperative and postoperative serum samples of 35 patients with different congenital gastrointestinal anomalies were analyzed for the markers CEA, CA 125 and 19-9 by immunoradiometric assay during a period of three years. The majority of the anomalies were aganglionic megacolon and hypertrophic pyloric stenosis. CA 125 and CA 19-9 were likely to indicate logistic model probabilities for babies with anomalies, while CEA was not (F=35.78, p<0.05 for CA CA 125 and F=4.36, p<0.05 for CA 19-9). Probability of no congenital anomaly for babies was: